- Work address:
-
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
E-pub date: 1 Aug 2023Journal name: Front Pharmacol
Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
E-pub date: 1 Aug 2023Journal name: Front Pharmacol
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial
E-pub date: 25 Jul 2023Journal name: Nat Commun